Oryzon Genomics SA Cash Flow Reinvestment Rate
Oryzon Genomics SA cash flow reinvestment rate. Oryzon Genomics SA (ORY) has a Cash Flow Reinvestment Rate of 0.17x as of December 2015, reinvesting €87.70K (capex €87.70K ) from operating cash flow of €523.10K. Explore Oryzon Genomics SA cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Oryzon Genomics SA (2013–2015)
Cash flow reinvestment rate of Oryzon Genomics SA from 2013 to 2015. Historical reinvestment intensity for Oryzon Genomics SA across 3 annual periods. Explore ORY capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Oryzon Genomics SA Cash Flow Reinvestment Rate by Year (2013–2015)
Oryzon Genomics SA cash flow reinvestment rate by year from 2013 to 2015. Year-by-year capital reinvestment analysis for Oryzon Genomics SA. For the full cash flow conversion analysis, see ORY cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 6.74x | €3.53 Million | €523.14K | €87.65K | ▲ +2244.9% |
| 2014 | 0.29x | €3.49 Million | €12.13 Million | €47.00K | ▼ 0.0% |
| 2013 | 0.29x | €3.49 Million | €12.13 Million | €47.30K | — |